Trademark Overview
On Thursday, August 15, 2024, a trademark application was filed for N-TAB with the United States Patent and Trademark Office. The USPTO has given the N-TAB trademark a serial number of 79413262. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, February 20, 2025. This trademark is owned by Entera Bio Ltd.. The N-TAB trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug delivery agents that facilitate the delivery of pharmaceutical preparations.
Licensing of intellectual property; licensing of technology.
Research and development services in the field of pharmaceutical preparations; development of pharmaceutical preparations and medicines; scientific research in the medical and pharmaceutical field, and consultancy and information relating thereto; design and development of new technology for others relating to oral delivery of proteins and peptides, and consultancy and information services relating thereto; research and development in the field of drug delivery systems.
